We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

4 hedge funds and large institutions have $4.15M invested in Intra-Cellular Therapies Inc. in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 389 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 395 → 4 (-391)

100% less capital invested

Capital invested by funds: $13.6B → $4.15M (-$13.6B)

100% less funds holding in top 10

Funds holding in top 10: 52 → 0 (-52)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 389

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
-391
Holders Change %
-98.99%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-52
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
389
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$1.26B
2
BlackRock
BlackRock
New York
-$1.15B
3
PCM
Pentwater Capital Management
Florida
-$685M
4
HI
HBK Investments
Texas
-$578M
5
Norges Bank
Norges Bank
Norway
-$472M
Name Holding Trade Value Shares
Change 		Change in
Stake
Mariner
251
Mariner
Kansas
– -$649K -4,921 Closed
OAM
252
Oxford Asset Management
United Kingdom
– -$639K -4,845 Closed
MSRPS
253
Maryland State Retirement & Pension System
Maryland
– -$635K -4,810 Closed
PAM
254
Panagora Asset Management
Massachusetts
– -$629K -4,766 Closed
UB
255
UMB Bank
Missouri
– -$610K -4,622 Closed
VHAM
256
Van Hulzen Asset Management
California
– -$607K -4,600 Closed
IA
257
IFP Advisors
Florida
– -$586K -4,440 Closed
KBC Group
258
KBC Group
Belgium
– -$540K -4,096 Closed
M&T Bank
259
M&T Bank
New York
– -$536K -4,061 Closed
OAM
260
OP Asset Management
– -$522K -3,958 Closed
PCA
261
Pallas Capital Advisors
Massachusetts
– -$520K -3,942 Closed
HighTower Advisors
262
HighTower Advisors
Illinois
– -$509K -3,858 Closed
Jones Financial Companies
263
Jones Financial Companies
Missouri
– -$504K -3,822 Closed
GCM
264
Graham Capital Management
Connecticut
– -$500K -3,791 Closed
AWM
265
Apollon Wealth Management
South Carolina
– -$484K -3,671 Closed
JG
266
Jain Global
New York
– -$475K -3,600 Closed
Mirae Asset Global Investments
267
Mirae Asset Global Investments
South Korea
– -$469K -3,560 Closed
DA
268
DCF Advisers
Connecticut
– -$462K -3,500 Closed
ONB
269
Old National Bancorp
Indiana
– -$462K -3,500 Closed
Cetera Investment Advisers
270
Cetera Investment Advisers
Illinois
– -$460K -3,487 Closed
CCP
271
Clough Capital Partners
Massachusetts
– -$449K -3,400 Closed
TSS
272
Two Sigma Securities
New York
– -$435K -3,300 Closed
QCM
273
QRG Capital Management
Illinois
– -$434K -3,288 Closed
Focus Partners Wealth
274
Focus Partners Wealth
Massachusetts
– -$424K -3,214 Closed
Simplex Trading
275
Simplex Trading
Illinois
– -$423K -3,214 Closed
9 10
11
12 13

ITCI Hedge Fund Activity: Q2 2025 in Review

4 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q2 2025, worth a combined $4.15M — down 100% from $13.6B a quarter earlier.

Sellers outnumbered buyers: 389 funds closed out of ITCI and 0 opened new positions — a net loss of 389 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $1.26B sold.

  • 4 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q2 2025, down from 395 in Q1 2025.
  • Funds reported $4.15M of Intra-Cellular Therapies Inc. stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Intra-Cellular Therapies Inc. positions in Q2 2025 and 389 closed out, a net change of -389 holders.
  • The largest Intra-Cellular Therapies Inc. seller in Q2 2025 was Vanguard Group, an estimated $1.26B sold.

Based on aggregated 13F filings for Q2 2025.